HCPCS code J7503: Tacrolimus ER, envarsus XR, per 0.25 mg2026 Medicare rate & RVUs in Washington
This code reports oral Envarsus XR extended-release tacrolimus by 0.25-mg unit for drug claims when Medicare covers the medication.
CMS doesn’t publish an office rate for J7503 in Washington.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What J7503 covers
J7503 identifies oral Envarsus XR, an extended-release tacrolimus product used as immunosuppression to help prevent rejection after kidney transplantation. It is distinct from immediate-release tacrolimus, other extended-release tacrolimus products, and tacrolimus granules prepared as an oral suspension. Transplant clinicians prescribe and manage this maintenance therapy; the drug claim identifies the Envarsus XR formulation furnished.
CMS assigns status E, excluding J7503 from the physician fee schedule. When Medicare covers the item, payment is made under another method; CMS classifies it as a Part B drug generally priced through the quarterly ASP drug files. Special Medicare coverage instructions apply. Each unit represents 0.25 mg of tacrolimus, so a 1-mg amount is reported as 4 units.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where J7503 pays more and less in Washington
| Payment locality | Office | Facility |
|---|---|---|
| King County, WA | Unavailable | Unavailable |
| Rest of Washington | Unavailable | Unavailable |
How the J7503 rate is calculated
Each of J7503’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · J7503
RVUs × geographic indexes × conversion factor
Work0.00
0.00 RVUs× 1.000 GPCI
Practice expense0.00
0.00 RVUs× 1.000 GPCI
Malpractice0.00
0.00 RVUs× 1.000 GPCI
Adjusted RVUs
0.0000
Conversion factor
$33.4009
Medicare rate
$0.00
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for J7503
J7503 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · J7503
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
POS 11 · non-facility rate · national
—
J7503 isn’t priced in this setting.
J7503 compared with similar codes
Compare codes · National
4 codes, side by side
How to choose
- J7507Oral tacrolimusImmediate release, per 1 mg
- J7503 identifies extended-release Envarsus XR; J7507 identifies immediate-release oral tacrolimus.
- J7508Extended-release tacrolimusPer 0.1 mg
- Both represent oral extended-release tacrolimus, but J7503 identifies Envarsus XR and J7508 identifies Astagraf XL.
- J7521Tacrolimus granulesOral suspension, per 0.1 mg
- J7521 identifies tacrolimus granules for oral suspension; J7503 identifies the Envarsus XR extended-release product.
J7503 billing questions
How does J7503 differ from J7507?
J7503 identifies oral extended-release Envarsus XR. J7507 identifies immediate-release oral tacrolimus.
How many units represent 1 mg?
Each unit represents 0.25 mg, so 1 mg corresponds to 4 units.
How does J7503 differ from J7508?
Both identify oral extended-release tacrolimus, but J7503 is for Envarsus XR and J7508 is for Astagraf XL.
Does status E mean Medicare never pays for this drug?
No. Status E excludes the code from the physician fee schedule. When Medicare covers the drug, payment is made under another method.
What payment method is identified for a covered claim?
CMS classifies J7503 as a Part B drug generally priced through quarterly Average Sales Price drug files.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Fee sheets · Coming soon
Put J7503 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist